SEC Form D · filed August 19, 2016
Aridis Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
John K. Hamilton · San Jose, CADirectorRobert R. Ruffolo, Jr · San Jose, CADirectorFred Kurland · San Jose, CAExecIsaac R. Blech · San Jose, CADirectorVu Truong · San Jose, CAExec · DirectorPaul-Andre De Lame · San Jose, CAExecCraig K. Gibbs · San Jose, CADirectorRobert K. Coughlin · San Jose, CADirectorEric Patzer · San Jose, CAExec · DirectorTim M. Flynn · Riverside, CAExec · DirectorNasiba Hartland-Mackie · Dallas, TXDirectorWilliam Rutledge · Pacific Palisades, CADirectorNicholas Naclerio · San Francisco, CAExecMamadou S. Diallo · Pasadena, CADirectorThomas Hartland-Mackie · Dallas, TXDirectorAlan S. Jarrick · Huntington Beach, CAExec · DirectorMichael E. Keller · Greenwich, CTExecBradley Messmer · San Diego, CAExec · DirectorNeil Senturia · San Diego, CADirectorRichard D. Carlson · Gainesville, FLExec · DirectorWilliam D. Pruitt · CORAL GABLES, FLDirectorBrett S. Harrison · Denver, COExecAdam B. Antoniades · San Diego, CAExecBernie Breton · Denver, CODirectorElizabeth C. Williamson · Chicago, ILDirectorCassandra A. Knight · Oshkosh, WIDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗